Healthcare -
Biotechnology - NASDAQ - FR
$ 1.8355
-2.53 %
$ 154 M
Market Cap
-2.76
P/E
IPHA - SHORT-TERM INVESTMENTS
Short-term Investments IPHA - Innate Pharma S.A.
21.9 M
LAST VALUE
16.57%
2 YEAR CAGR
7.50%
5 YEAR CAGR
22.01%
10 YEAR CAGR